Trugen Pharmaceuticals Private Limited

Trugen Pharmaceuticals Private Limited - pharma in Roorkee, Uttarakhand, India. FY 2026 financials & compliance.
CIN U24232UT2005PTC020220 Incorporated 08 July 2005 ROC Uttarakhand HQ Roorkee, Uttarakhand, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹19.49 Cr
▼ 11% YoY
Net profit · FY 2025
₹29.61 Lakh
Net margin 1.5%
EBITDA · FY 2025
₹1.78 Cr
EBITDA margin 9.1%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹75.16 Lakh
Issued & subscribed
Open charges
₹6.03 Cr
Satisfied ₹2.23 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
26
Provident fund records

About Trugen Pharmaceuticals Private Limited

Data last updated:

Trugen Pharmaceuticals Private Limited is a private limited company based in Roorkee, Uttarakhand, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 July 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24232UT2005PTC020220. Its GSTIN is 05AACCT3174D1ZO (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹75.16 Lakh. It was formerly known as Bss Buildcon Private Limited. It is led by directors including Vivek Garg (Managing Director) and Monika Garg.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Roorkee, Uttarakhand.

As per the financials filed for FY 2025, the company reported a revenue of ₹19.49 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹29.61 Lakh (net margin 1.5%) and EBITDA of ₹1.78 Cr (EBITDA margin 9.1%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 4% over five years.

The company has about 26 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Trugen Pharma. As per MCA filings, the company has open charges of ₹6.03 Cr and satisfied charges of ₹2.23 Cr on record. Court records list 23 cases involving the company, including 4 filed by the company and 19 filed against it; 11 cases are pending.

Trugen Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0004624). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website trugenpharma.com.

Company details

CIN U24232UT2005PTC020220
Registration Number 020220
Incorporation Date 08 July 2005
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-06-0004624

CIN history

Trugen Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24232UT2005PTC020220, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232UT2005PTC020220Current
U24232DL2005NPL138478Previous
U24232DL2005PTC138478Previous
Key People
Vivek Garg Managing Director Monika Garg Director Neelesh Garg Director

Recognitions & Rankings of Trugen Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-UK-06-0004624

Contact details

Trugen Pharmaceuticals Private Limited's registered office is in Roorkee, Uttarakhand.

  • Registered Address
    Village Tejupur, Bhagwanpur, Roorkee, Uttarakhand, India – 247667
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Trugen Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Trugen Pharmaceuticals operates one associated brand: Trugen Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Trugen Pharma
Manufacturing and supplying pharmaceutical drugs with a focus on research and exports.trugenpharma.com

Business activity

The main business activity of Trugen Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Trugen Pharmaceuticals Private Limited, buy the company report.

Financials of Trugen Pharmaceuticals Private Limited

FY 2024 filings available

Trugen Pharmaceuticals Private Limited reported revenue of ₹19.49 Cr (down 11% YoY) for FY 2025.

Revenue · FY 2025
₹19.49 Cr ▼ 11%
Net profit · FY 2025
₹29.61 Lakh margin 1.5%
EBITDA · FY 2025
₹1.78 Cr margin 9.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▼ 3%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▲ 102%
3 years · compounded
▲ 14%
5 years · compounded
▼ 1%

Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 11% fall in the latest year. EBITDA rose 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.78 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹29.61 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.1%
Net Profit Margin1.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Trugen Pharmaceuticals Private Limited, buy the company report.

Board of directors of Trugen Pharmaceuticals Private Limited

Trugen Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Monika Garg
Also directs: Trugen Neurosciences Private Limited
Director03 Jan 20188 Years 10 MonthsCurrent
Vivek Garg
Also directs: Trugen Neurosciences Private Limited
Managing Director08 Jul 200521 Years 4 MonthsCurrent
Neelesh GargDirector04 Apr 20251 Years 7 MonthsCurrent
View all directors

Peer comparison

Trugen Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Xenon Pharma Private Limited₹19.65 Cr (FY 2024)28.0%New Delhi, Delhi, India
Estrellas Life Sciences Private Limited₹19.63 Cr (FY 2025)8.0%Ahmedabad, Gujarat, India
Tamarugatam Pharmaceuticals Private Limited₹19.59 Cr (FY 2024)3.0%Chennai, Tamil Nadu, India
Trugen Pharmaceuticals Private Limitedthis company₹19.49 Cr (FY 2025)₹29.61 Lakh1.5%-11.0%Roorkee, Uttarakhand, India
Jarun Pharmaceuticals Private Limited₹19.49 Cr (FY 2025)6.0%Ahmedabad, Gujarat, India
Vaks Pharma Private Limited₹19.45 Cr (FY 2024)28.0%Mumbai, Maharashtra, India

To see the full peer comparison of Trugen Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹6.03 Cr
Satisfied charges
₹2.23 Cr
Breakdown by lending institutions
Indian Overseas Bank₹6.03 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
25 Jul 2024100974522Indian Overseas Bank₹38 LakhOpen
13 Mar 2023100694446Indian Overseas Bank₹1 CrOpen
25 Feb 2022100547397Indian Overseas Bank₹46 LakhOpen
25 Nov 2021100512068Indian Overseas Bank₹1 CrOpen
22 Sep 2021100489211Indian Overseas Bank₹20 LakhOpen

To see the full charge records of Trugen Pharmaceuticals Private Limited, buy the company report.

Total charge records: 12 View all charges

MSME payment delays

Trugen Pharmaceuticals Private Limited has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 219 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 6)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
Alutech Packaging Private Limited
Darbari Enterprises
Ganesh Metal Industries

To see the full MSME payment records of Trugen Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Trugen Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
05AACCT3174D1ZOUttarakhandActive01 Jul 2017

To see the full GST registrations and return filing status of Trugen Pharmaceuticals Private Limited, buy the company report.

Recent activity

Trugen Pharmaceuticals Private Limited has 8 board changes on record since 2005: 3 appointments and 5 cessations. The latest: Neelesh Garg ceased to be Additional Director on 29 Sep 2025.

Ceased
Neelesh Garg ceased to be Additional Director.
Charges
A charge registered on 24 Jul 2020 via Charge ID 100359588 with Indian Overseas Bank was fully satisfied on 02 Jun 2025.
Charges
A charge with Indian Overseas Bank of Rs. 2.28 Cr registered on 30 Sep 2019 with Charge ID 100296428 was modified on 31 May 2025.
Ceased
Anuj Kumar ceased to be Director.
Appointed
Neelesh Garg was appointed as Director.
AGM
Trugen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Indian Overseas Bank amounted to Rs. 0.38 Cr with Charge ID 100974522 was registered on 25 Jul 2024.
Filing
Trugen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand.
Charges
A charge with Indian Overseas Bank amounted to Rs. 1.00 Cr with Charge ID 100694446 was registered on 13 Mar 2023.
Charges
A charge with Indian Overseas Bank amounted to Rs. 0.46 Cr with Charge ID 100547397 was registered on 25 Feb 2022.
Charges
A charge with Indian Overseas Bank amounted to Rs. 1.00 Cr with Charge ID 100512068 was registered on 25 Nov 2021.
Charges
A charge with Indian Overseas Bank amounted to Rs. 0.20 Cr with Charge ID 100489211 was registered on 22 Sep 2021.

18 earlier events are in the company report.

Frequently asked questions

Trugen Pharmaceuticals is an active private limited company based in Roorkee, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 July 2005 (21+ years old) and is registered under CIN U24232UT2005PTC020220.

Trugen Pharmaceuticals has 3 current directors:

The latest financial statements of Trugen Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Trugen Pharmaceuticals is 05AACCT3174D1ZO, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Trugen Pharmaceuticals is U24232UT2005PTC020220. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Trugen Pharmaceuticals has 23 court cases on record: 4 filed by the company and 19 filed against it. 11 are pending. Most are in the district courts.

Trugen Pharmaceuticals was incorporated on 08 July 2005, making it 21+ years old. It is registered with the Registrar of Companies, Uttarakhand.

The peers of Trugen Pharmaceuticals by revenue are Xenon Pharma Private Limited, Estrellas Life Sciences Private Limited, Tamarugatam Pharmaceuticals Private Limited, Jarun Pharmaceuticals Private Limited, Vaks Pharma Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).

Neelesh Garg ceased to be Additional Director on 29 Sep 2025. Anuj Kumar ceased to be Director on 04 Apr 2025. Neelesh Garg was appointed as Director on 04 Apr 2025. Trugen Pharmaceuticals has 8 board changes on record in total.

Yes, Trugen Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0004624).

Trugen Pharmaceuticals has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 219 overdue payments to 6 micro and small suppliers. The latest return was filed on 02 Dec 2019.

Trugen Pharmaceuticals can be reached through the website trugenpharma.com. Its registered office is in Roorkee, Uttarakhand, India.